Report Materials
This report consolidates the results of our reviews of six selected Medicare Part B providers in Alaska, Arizona, and Washington that billed Medicare for Neulasta injections. For 156 Medicare claims reviewed, the 6 providers billed Medicare for the incorrect number of service units of Neulasta. Consequently, during calendar years 2004 through 2007, Medicare contractors overpaid these providers $153,000.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.